Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_assertion type Assertion NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_head.
- NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_assertion description "[Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_provenance.
- NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_assertion evidence source_evidence_literature NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_provenance.
- NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_assertion SIO_000772 21529986 NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_provenance.
- NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_assertion wasDerivedFrom befree-20150227 NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_provenance.
- NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_assertion wasGeneratedBy ECO_0000203 NP907693.RAXEuMmBgLeSi292SRN8A7NoC_h8MzzCrdPaKwyx8lQaU130_provenance.